DOI:
10.1055/s-00000049
Clinics in Colon and Rectal Surgery
LinksClose Window
References
Kang YK, Ryu MH, Yoo C. , et al.
Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial.
Lancet Oncol 2013;
14 (12) 1175-1182
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.